Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

59 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effects of food on the pharmacokinetics of ponatinib in healthy subjects.
Narasimhan NI, Dorer DJ, Niland K, Haluska F, Sonnichsen D. Narasimhan NI, et al. Among authors: dorer dj. J Clin Pharm Ther. 2013 Dec;38(6):440-4. doi: 10.1111/jcpt.12082. Epub 2013 Jul 25. J Clin Pharm Ther. 2013. PMID: 23888935 Free PMC article. Clinical Trial.
Effects of Strong CYP2C8 or CYP3A Inhibition and CYP3A Induction on the Pharmacokinetics of Brigatinib, an Oral Anaplastic Lymphoma Kinase Inhibitor, in Healthy Volunteers.
Tugnait M, Gupta N, Hanley MJ, Sonnichsen D, Kerstein D, Dorer DJ, Venkatakrishnan K, Narasimhan N. Tugnait M, et al. Among authors: dorer dj. Clin Pharmacol Drug Dev. 2020 Feb;9(2):214-223. doi: 10.1002/cpdd.723. Epub 2019 Jul 9. Clin Pharmacol Drug Dev. 2020. PMID: 31287236 Free PMC article. Clinical Trial.
Analysis of the potential effect of ponatinib on the QTc interval in patients with refractory hematological malignancies.
Sonnichsen D, Dorer DJ, Cortes J, Talpaz M, Deininger MW, Shah NP, Kantarjian HM, Bixby D, Mauro MJ, Flinn IW, Litwin J, Turner CD, Haluska FG. Sonnichsen D, et al. Among authors: dorer dj. Cancer Chemother Pharmacol. 2013 Jun;71(6):1599-607. doi: 10.1007/s00280-013-2160-7. Epub 2013 Apr 23. Cancer Chemother Pharmacol. 2013. PMID: 23609479 Free PMC article. Clinical Trial.
Activity and safety of brigatinib in ALK-rearranged non-small-cell lung cancer and other malignancies: a single-arm, open-label, phase 1/2 trial.
Gettinger SN, Bazhenova LA, Langer CJ, Salgia R, Gold KA, Rosell R, Shaw AT, Weiss GJ, Tugnait M, Narasimhan NI, Dorer DJ, Kerstein D, Rivera VM, Clackson T, Haluska FG, Camidge DR. Gettinger SN, et al. Among authors: dorer dj. Lancet Oncol. 2016 Dec;17(12):1683-1696. doi: 10.1016/S1470-2045(16)30392-8. Epub 2016 Nov 8. Lancet Oncol. 2016. PMID: 27836716 Clinical Trial.
59 results